Purebase Appoints Dr. Amy T. Clemens as Chief Financial Officer
PUBC has more than doubled off its 52-week low of $0.002.
Summary
Purebase Corp appointed Dr. Amy T. Clemens as its new CFO, filling a key leadership role amidst the company's ongoing financial challenges and recent executive changes.
Key Events · Executive and Board Changes · PUBC
-
New Chief Financial Officer Appointed
Dr. Amy T. Clemens was appointed Chief Financial Officer, effective June 4, 2026, filling the vacancy left by the previous CFO's termination in April 2026.
-
Return of Former CFO
Dr. Clemens previously served as the company's CFO from February 2014 to April 2016, bringing prior institutional knowledge to the role during a period of significant financial activity.
-
Experienced Financial Leader
Dr. Clemens has extensive financial and operational experience, including co-owning and serving as CFO/COO for OPTEC Solutions LLC since January 2008.
Analysis · PUBC · Industrial Applications And Services
Purebase Corp, a micro-cap company facing significant financial challenges including a "going concern" warning, has appointed Dr. Amy T. Clemens as its new Chief Financial Officer. This appointment fills a critical leadership vacancy following the termination of the previous CFO in April, and Dr. Clemens' prior experience with the company from 2014-2016 provides valuable continuity and expertise during a period of ongoing financial restructuring and strategic shifts.
How filings like this one have moved
In the 30 days to Sep 20, 2026, 29.4% of the 1574 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PUBC was trading at $0.02 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $5.8M. The 52-week trading range was $0.00 to $0.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.